CERGA Journal Title and Abstracts December 2011
Contents / pAGELIST OF JOURNALS CHECKED / 2
List of references
Alcohol / 3
Alcohol – Burden on Society / 3
Alcohol – Epidemiology and Demography / 4
Alcohol – Liver Disease / 4
Alcohol – Miscellaneous / 4
Alcohol – Treatment and Screening / 5
Alcohol Use – Binge Drinking / 6
Benzodiazepines / 6
Blood Borne Viruses / 6
Co-Morbidity / 6
Drug Policy / 7
Drug Related Deaths / 7
Epidemiology and Demography / 8
Homelessness / 8
Injecting Behaviour / 9
Opiate Treatment / 9
Opiate Treatment – Pregnancy / 11
OTC/ Prescription misuse / 11
Policy / 11
Services and Professionals / 11
Stimulants / 11
Treatment and Service Use / 12
LIST OF ABSTRACTS / 13-61
Journal Title / Volumes and Issues Checked / Number of issues per year
Addiction / Volume 106, Issue 10[4], Issue 11[3],
Issue 12[4] / 12
Addictive Behaviours / Volume 36, Issue 10[1], Issue 11[1],
Issue 12[5] / 12
Addictive Disorders & Their Treatment / Volume 10, Issue 4 – December[1] / 4
Alcohol and Alcoholism / Volume 46 issue 6 November-December[2] / 6
Alcoholism Clinical & Experimental Research / Volume 35, Issue 9[2], Issue 10[3],
Issue 11[3], Issue 12[2] / 12
BMJ / Special topic search 2011
Drug and Alcohol Dependence / Volume 118, Issue 1 (October)[2], Issues 2-3 (November)[12]
Volume 119 Issues 1-2 (October-December) [6] / 21
Drug and Alcohol Review / Volume 30 Issue 5[4], Issue 6[3] / 6
European Addiction Research / Volume 17 Issue 6[1] / 4-5
International Journal of Drug Policy / Volume 22 Issue 5[3] / 6
Journal of Addictive Diseases / Volume 30, Issue 4[1] / 4
Journal of Substance Abuse Treatment / Volume 41, Issue 3[1], Issue 4[4] / 8
The American Journal of Drug and Alcohol Abuse / Volume 37 Issue 6 (November)[1] / 6
Journal of Substance Use / Volume 16 Issue 6[1] / 6
LIST OF REFERENCES
ALCOHOL
1. Maternal risk factors predicting child physical characteristics and dysmorphology in fetal alcohol syndrome and partial fetal alcohol syndrome
Philip A. May, Barbara G. Tabachnick, J. Phillip Gossage, Wendy O. Kalberg, Anna-Susan Marais, Luther K. Robinson, Melanie Manning, David Buckley, H. Eugene Hoyme
Drug and Alcohol Dependence 2011:119(1-2);18-27
ALCOHOL – BURDEN ON SOCIETY
2. Access to alcohol outlets and harmful alcohol consumption: a multi-level study in Melbourne, Australia
Anne M. Kavanagh, Mary T. Kelly, Lauren Krnjacki, Lukar Thornton, Damien Jolley,
S. V. Subramanian, Gavin Turrell, Rebecca J. Bentley
Addiction 2011: 106(10);1772-1779
3. Strategies to increase community-based intervention research aimed at reducing excessive alcohol consumption and alcohol-related harm
Conor Gilligan, Rob Sanson-Fisher, Amy E Anderson, Catherine D’Este
Drug and Alcohol Review 2011:30(6);659-663
4. The impact of retail practices on violence: The case of single serve alcohol beverage containers
Robert Nash Parker, Kevin J McCaffree, Daniel Skiles
Drug and Alcohol Review 2011:30(5);496-504
5. Alcohol outlet density and harm: Comparing the impacts on violence and chronic harms
Michael Livingston
Drug and Alcohol Review 2011:30(5);515-523
6. Revealing the link between licensed outlets and violence: Counting venues versus measuring alcohol availability
Wenbin Liang, Tanya Chikritzhs
Drug and Alcohol Review 2011:30(5);524-535
7. Getting drunk safely? Night-life policy in the UK and its public health consequences
Mark A Bellis, Karen Hughes
Drug and Alcohol Review 2011:30(5);536-545
ALCOHOL – EPIDEMIOLOGY AND DEMOGRAPHY
8. Alcohol Dependence in Men: Reliability and Heritability
Eivind Ystrom, Ted Reichborn-Kjennerud, Steven H. Aggen, Kenneth S. Kendler
Alcoholism: Clinical and Experimental Research 2011:35(9);1716-1722
9. Impulsivity Is an Independent Predictor of 15-Year Mortality Risk Among Individuals Seeking Help for Alcohol-Related Problems
Daniel M. Blonigen, Christine Timko, Bernice S. Moos, Rudolf H. Moos
Alcoholism: Clinical and Experimental Research 2011:35(11);2082-2092
10. Birth Cohort Effects and Gender Differences in Alcohol Epidemiology: A Review and Synthesis
Katherine M. Keyes, Guohua Li, Deborah S. Hasin
Alcoholism: Clinical and Experimental Research 2011:35(12);2101-2112
11. Mortality in alcohol use disorder in the Lundby Community Cohort—A 50 year follow-up
C. Mattisson, M. Bogren, A. Öjehagen, G. Nordström, V. Horstmann
Drug and Alcohol Dependence 2011:118(2-3);141-147
ALCOHOL – LIVER DISEASE
12. S-adenosyl-L-methionine Treatment for Alcoholic Liver Disease: A Double-Blinded, Randomized, Placebo-Controlled Trial
Valentina Medici, Maria C. Virata, Janet M. Peerson, Sally P. Stabler, Samuel W. French, Jesse F. Gregory III, Anthony Albanese, Christopher L. Bowlus, Sridevi Devaraj, Edward A. Panacek, John R. Richards, Charles H. Halsted
Alcoholism: Clinical and Experimental Research 2011:35(11);1960-1965
ALCOHOL – MISCELLANEOUS
13. Dissociation Between Affective and Cognitive Empathy in Alcoholism: A Specific Deficit for the Emotional Dimension
Pierre Maurage, Delphine Grynberg, Xavier Noël, Frédéric Joassin, Pierre Philippot, Catherine Hanak, Paul Verbanck, Olivier Luminet, Philippe de Timary, Salvatore Campanella
Alcoholism: Clinical and Experimental Research 2011:35(9)1662-1668
14. Alcohol Has a Dose-Related Effect on Parasympathetic Nerve Activity During Sleep
Yohei Sagawa, Hideaki Kondo, Namiko Matsubuchi, Takaubu Takemura, Hironobu Kanayama, Yoshihiko Kaneko, Takashi Kanbayashi, Yasuo Hishikawa, Tetsuo Shimizu
Alcoholism: Clinical and Experimental Research 2011:35(11);2093-2100
ALCOHOL – TREATMENT AND SCREENING
15. Brief interventions in routine health care: a population-based study of conversations about alcohol in Sweden
Per Nilsen, Jim McCambridge, Nadine Karlsson, Preben Bendtsen
Addiction 2011: 106(10); 1748-1756
16. Extended telephone-based continuing care for alcohol dependence: 24-month outcomes and subgroup analyses
James R. McKay, Deborah Van Horn, David W. Oslin, Megan Ivey, Michelle L. Drapkin,
Donna M. Coviello, Qin Yu, Kevin G. Lynch
Addiction 2011: 106(10); 1760-1769
17. The potential cost-effectiveness of general practitioner delivered brief intervention for alcohol misuse: Evidence from rural Australia
Héctor José Navarro, Anthony Shakeshaft, Christopher M. Doran, Dennis J. Petrie
Addictive Behaviors 2011:36(12);1191-1198
18. The Efficacy of Disulfiram for the Treatment of Alcohol Use Disorder
Charlotte H. Jørgensen, Bolette Pedersen, Hanne Tønnesen
Alcoholism: Clinical and Experimental Research 2011:35(10);1749-1758
19. Efficacy of Extended-Release Naltrexone in Patients with Relatively Higher Severity of Alcohol Dependence
Helen M. Pettinati, Bernard L. Silverman, John J. Battisti, Robert Forman, Edward Schweizer, David R. Gastfriend
Alcoholism: Clinical and Experimental Research 2011:35(10);1804-1811
20. Is Brief Motivational Intervention Effective in Reducing Alcohol Use Among Young Men Voluntarily Receiving It? A Randomized Controlled Trial
Jacques Gaume, Gerhard Gmel, Mohamed Faouzi, Nicolas Bertholet, Jean-Bernard Daeppen
Alcoholism: Clinical and Experimental Research 2011:35(10);1822-1830
21. Promoting Behavior Change from Alcohol Use Through Mobile Technology: The Future of Ecological Momentary Assessment
Amy M. Cohn, Dorian Hunter-Reel, Brett T. Hagman, Jessica Mitchell
Alcoholism: Clinical and Experimental Research 2011:35(12);2209-2215
22. Fifty years of brief intervention effectiveness trials for heavy drinkers
Jim McCambridge
Drug and Alcohol Review 2011:30(6);567-568
ALCOHOL USE – BINGE DRINKING
23. Alcohol, violence, and the alcohol myopia model: Preliminary findings and implications for prevention
Peter R. Giancola, Aaron A. Duke, Katalin Z. Ritz
Addictive Behaviors 2011:36(10);1019-1022
24. The Influence of Alcohol Intake and Alcohol Expectations on the Recognition of Emotions
Nora T. Walter, Smiljana Mutic, Sebastian Markett, Christian Montag, Alisa M. Klein,Martin Reuter
Alcohol and Alcoholism 2011:46(6);680-685
BENZODIAZEPINE
25. Benzodiazepine dependence among multidrug users in the club scene
Steven P. Kurtz, Hilary L. Surratt, Maria A. Levi-Minzi, Angela Mooss
Drug and Alcohol Dependence 2011:119(1-2);99-105
BLOOD BORNE VIRUSES
26. Commentary on Gibson etal. (2011): Brief alcohol interventions in the context of treatment for hepatitis C
Michael A. Cucciare, Kenneth R. Weingardt
Addiction 2011:106(12); 2193-2194
27. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence
Katy M. E. Turner, Sharon Hutchinson, Peter Vickerman, Vivian Hope, Noel Craine, Norah Palmateer, Margaret May, Avril Taylor, Daniela De Angelis, Sheila Cameron, John Parry, Margaret Lyons, David Goldberg, Elizabeth Allen, Matthew Hickman
Addiction 2011: 106(11); 1978-1988
CO-MORBIDITY
28. Co-occurrence of obsessive-compulsive disorder and substance use disorder in the general population
Rianne M. Blom, Maarten Koeter, Wim van den Brink, Ron de Graaf, Margreet ten Have, Damiaan Denys
Addiction 2011:106(12);2178–2185
29. Clinical Experience with Baclofen in the Management of Alcohol-Dependent Patients with Psychiatric Comorbidity: A Selected Case Series
G.M. Dore , K. Lo , L. Juckes , S. Bezyan, N. Latt
Alcohol and Alcoholism 2011:46 (6);714-720
30. Prolonged use of benzodiazepines is associated with childhood trauma in opioid-maintained patients
Marc Vogel, Kenneth M. Dürsteler-MacFarland, Marc Walter, Johannes Strasser, Stephanie Fehr, Luis Prieto, Gerhard A. Wiesbeck
Drug and Alcohol Dependence 2011:119(1-2);93-98
31. An examination of psychiatric comorbidities as a function of gender and substance type within an inpatient substance use treatment program
Kevin W. Chen, Annie N. Banducci, Leila Guller, Richard J. Macatee, Anna Lavelle, Stacey B. Daughters, C.W. Lejuez
Drug and Alcohol Dependence 2011:118(2-3);92-99
32. Predictors of clinical trial dropout in individuals with co-occurring bipolar disorder and alcohol dependence
James J. Prisciandaro, Julie Rembold, Delisa G. Brown, Kathleen T. Brady, Bryan K. Tolliver
Drug and Alcohol Dependence 2011:118(2-3);493-496
33. Associations between substance use disorder sub-groups, life expectancy and all-cause mortality in a large British specialist mental healthcare service
Richard D. Hayes, Chin-Kuo Chang, Andrea Fernandes, Matthew Broadbent, William Lee, Matthew Hotopf, Robert Stewart
Drug and Alcohol Dependence 2011:118(1);56-61
DRUG POLICY
34. Let not the best be the enemy of the good
David Nutt
Addiction 2011:106(11);1892-1893
DRUG RELATED DEATHS
35. Risk of drug-related mortality during periods of transition in methadone maintenance treatment: A cohort study
Gráinne Cousins - cr0005#cr0005, Conor Teljeur, Nicola Motterlini, Colin McCowan, Borislav D. Dimitrov, Tom Fahey
Journal of Substance Abuse Treatment 2011:41(3);252-260
EPIDEMIOLOGY AND DEMOGRAPHY
36. Non-medical prescription use increases the risk for the onset and recurrence of psychopathology: results from the National Epidemiological Survey on Alcohol and Related Conditions
Ty S. Schepis, Jahn K. Hakes
Addiction 2011:106(12);2146-2155
37. The increasing mortality burden of liver disease among opioid-dependent people: cohort study
Amy Gibson, Deborah Randall, Louisa Degenhardt
Addiction 2011: 106(12);2186-2192
38. Pain response in heroin users: Personality, abstinence, and modulation by benzodiazepines
Ada Man Choi Ho, Ben Kin Leung Cheung, Alfreda Stadlin
Addictive Behaviors 2011:36(12);1361-1364
39. Illegal drug use and the economic recession—What can we learn from the existing research?
Anne Line Bretteville-Jensen
International Journal of Drug Policy 2011:22(5);353-359
40. Unemployment and drug treatment
Cláudia Costa Storti. Paul De Grauwe, Anna Sabadash, Linda Montanari
International Journal of Drug Policy 2011:22(5);366-373
41. Delay discounting, impulsiveness, and addiction severity in opioid-dependent patients
Elias Robles - cr0005#cr0005, B. Emma Huang, Pippa M. Simpson, Donald E. McMillan
International Journal of Drug Policy 2011:22(5);354-362
42. Could a continuous measure of individual transmissible risk be useful in clinical assessment of substance use disorder? Findings from the National Epidemiological Survey on Alcohol and Related Conditions
Ty A. Ridenour, Levent Kirisci, Ralph E. Tarter, Michael M. Vanyukov
Drug and Alcohol Dependence2011:119(1-2);10-17
HOMELESSNESS
43. Substance use and predictors of substance dependence in homeless women
Iris Torchalla, Verena Strehlau, Kathy Li, Michael Krausz
Drug and Alcohol Dependence 2011:118(2-3);173-179
44. The social context of homeless men's substance use
Harmony Rhoades, Suzanne L. Wenzel, Daniela Golinelli, Joan S. Tucker, David P. Kennedy, Harold D. Green, Annie Zhou
Drug and Alcohol Dependence 2011:118(2-3);320-325
INJECTING BEHAVIOUR
45. Using the health belief model to predict injecting drug users' intentions to employ harm reduction strategies
Erin E. Bonar, Harold Rosenberg
Addictive Behaviors 2011:36(11);1038-1044
46. A treatment reengagement intervention for syringe exchangers
Michael Kidorf - cr0005#cr0005, Van L. King, Jessica Peirce, Ken Kolodner, Robert K. Brooner
Journal of Substance Abuse Treatment 2011:41(4);415-421
47. Accessing a diverse sample of injection drug users in San Francisco through respondent-driven sampling
Mohsen Malekinejad, Willi McFarland, Jason Vaudrey, H. Fisher Raymond
Drug and Alcohol Dependence 2011:118(2-3);83-91
OPIATE TREATMENT
48. The role of self-efficacy in the treatment of substance use disorders
Ronald M. Kadden, Mark D. Litt
Addictive Behaviors2011: 36(12); 1120-1126
49. A 25-year follow-up of patients admitted to methadone treatment for the first time: Mortality and gender differences
Luis Jimenez-Treviño, Pilar A. Saiz, M. Paz García-Portilla, Eva M. Díaz-Mesa, Fernando Sánchez-Lasheras, Patricia Burón, M. José Casares, Pedro Marina, Eduardo Gutiérrez, Julio Bobes
Addictive Behaviors 2011:36(12);1184-1190
50. Clients' Self-efficacy and Outcome Expectations: Impact on Retention and Effectiveness in Outpatient Substance Abuse Treatment
Kuusisto Katja, Knuuttila Vesa, Saarnio Pekka
Addictive Disorders & Their Treatment 2011:10(4);157-168
51. Using ‘payment by results’ to fund the treatment of dependent drug users—proceed with care!
Alan Maynard, Andrew Street, Rachael Hunter
Addiction 2011:106(10);1725-1729
52. A Comparison of Cognitive Function in Patients under Maintenance Treatment with Heroin, Methadone, or Buprenorphine and Healthy Controls: An Open Pilot Study
Michael Soyka, Claudia Limmer, Robert Lehnert, Gabriele Koller, Gabriele Martin, Heinrich Küfner, Annina Haberthür
The American Journal of Drug and Alcohol Abuse 2011:37(6);497-508
53. The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: A review
Kelly E. Dunnn, Stacey C. Sigmon, Eric C. Strain, Sarah H. Heil, Stephen T. Higgins
Drug and Alcohol Dependence 2011;119(1-2);1-9
54. Clinician and service user perceptions of implementing contingency management: A focus group study
J.M.A. Sinclair, A. Burton, R. Ashcroft, S. Priebe
Drug and Alcohol Dependence 2011:119(1-2);56-63
55. 30-Year trajectories of heroin and other drug use among men and women sampled from methadone treatment in California
Christine E. Grella, Katherine Lovinger
Drug and Alcohol Dependence 2011:118(2-3);251-258
56. Health related quality of life trajectories of patients in opioid substitution treatment
Bohdan Nosyk, Daphne P. Guh, Huiying Sun, Eugenia Oviedo-Joekes, Suzanne Brissette, David C. Marsh, Martin T. Schechter, Aslam H. Anis
Drug and Alcohol Dependence 2011:118(2-3);259-264
57. Post-marketing surveillance of buprenorphine-naloxone in Australia: Diversion, injection and adherence with supervised dosing
Briony Larance, Louisa Degenhardt, Nick Lintzeris, James Bell, Adam Winstock, Paul Dietze, Richard Mattick, Robert Ali, Danielle Horyniak
Drug and Alcohol Dependence 2011:118(2-3);265-273
58. Gender differences in pharmacokinetics of maintenance dosed buprenorphine
David E. Moody, Wenfang B. Fang, Jerdravee Morrison, Elinore McCance-Katz
Drug and Alcohol Dependence 2011:118(2-3);479-483
59. Risky decision-making predicts short-term outcome of community but not residential treatment for opiate addiction. Implications for case management
F. Passetti, L. Clark, P. Davis, M.A. Mehta, S. White, K. Checinski, M. King, M. Abou-Saleh
Drug and Alcohol Dependence 2011:118(1);12-18
60. Prescribers' perceptions of the diversion and injection of medication by opioid substitution treatment patients
Briony Larance, Louisa Degenhardt, Susannah O’Brien, Nick Lintzeris, Adam Winstock, Richard P Mattick, James Bell, Robert Ali
Drug and Alcohol Review 2011:30(6);613-620
61. Efficacy versus Effectiveness of Buprenorphine and Methadone Maintenance in Pregnancy
Robert G. Newman, Susan G. Gevertz
Journal of Addictive Diseases 2011:30(4);318-322
OPIATE TREATMENT – PREGNANCY
62. Changes in methadone maintenance therapy during and after pregnancy - foot1#foot1
Brittany Albright, Lesley de la Torre, Betty Skipper, Sylvia Price, Patrick Abbott, William Rayburn
Journal of Substance Abuse Treatment 2011:41(4);347-353 - cr0005#cr0005
OTC/PRESCRIPTION MISUSE
63. Decreased striatal dopamine transporters in codeine-containing cough syrup abusers
Haifeng Hou, Shugui Yin, Shaowei Jia, Shu Hu, Taotao Sun, Qing Chen, Rong Fan
Drug and Alcohol Dependence 2011:118(2-3);148-151
POLICY
64. Welfare, Temperance and Compulsory Commitment to Care for Persons with Substance Misuse Problems: A Comparative Study of 38 European Countries
Magnus Israelsson
European Addiction Research 2011:17(6);329-341
65. Economic recession, drug use and public health
Cláudia Costa Storti, Paul De Grauwe, Peter Reuter
International Journal of Drug Policy 2011:22(5);321-325
SERVICES AND PROFESSIONALS
66. A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatment
Traci R. Rieckmann - cr0005#cr0005, Anne E. Kovas, Bentson H. McFarland, Amanda J. Abraham
Journal of Substance Abuse Treatment 2011:41(4);374-385
67. National survey of alcohol treatment agencies in England: Characteristics of treatment agencies
Abigail Katherine Rose, Hannah Winfield, Jenny H. Jenner, Adenekan Oyefeso, Tom S. Phillips, Paulo Deluca, Katherine A. Perryman, Charlie Heriot-Maitland, Susanna Galea, Survjit Cheeta, Vivienne Saunders, & Colin Drummond
Journal of Substance Use 2011:16(6);407-421
STIMULANTS
68. Mephedrone: use, subjective effects and health risks
Adam Winstock, Luke Mitcheson, John Ramsey, Susannah Davies, Malgorzata Puchnarewicz, John Marsden
Addiction 2011 106(11);1991-1996
TREATMENT AND SERVICE USE
69. Correlates of perceiving a need for treatment among adults with substance use disorder: Results from a National Survey
Sarra L. Hedden, Joseph C. Gfroerer
Addictive Behaviors 2011:36(12);1213-1222
70. Parent training plus contingency management for substance abusing families: A Complier Average Causal Effects (CACE) analysis
Catherine Stanger, Stacy R. Ryan, Hongyun Fu, Alan J. Budney
Drug and Alcohol Dependence 2011:118(2-3);119-126
LIST OF ABSTRACTS
ALCOHOL
1. Maternal risk factors predicting child physical characteristics and dysmorphology in fetal alcohol syndrome and partial fetal alcohol syndrome
Philip A. May, Barbara G. Tabachnick, J. Phillip Gossage, Wendy O. Kalberg, Anna-Susan Marais, Luther K. Robinson, Melanie Manning, David Buckley, H. Eugene Hoyme
Drug and Alcohol Dependence 2011:119(1-2);18-27
Abstract
Background Previous research in South Africa revealed very high rates of fetal alcohol syndrome (FAS), of 46–89 per 1000 among young children. Maternal and child data from studies in this community summarize the multiple predictors of FAS and partial fetal alcohol syndrome (PFAS). Method Sequential regression was employed to examine influences on child physical characteristics and dysmorphology from four categories of maternal traits: physical, demographic, childbearing, and drinking. Then, a structural equation model (SEM) was constructed to predict influences on child physical characteristics. Results Individual sequential regressions revealed that maternal drinking measures were the most powerful predictors of a child's physical anomalies (R2 = .30, p < .001), followed by maternal demographics (R2 = .24, p < .001), maternal physical characteristics (R2 = .15, p < .001), and childbearing variables (R2 = .06, p < .001). The SEM utilized both individual variables and the four composite categories of maternal traits to predict a set of child physical characteristics, including a total dysmorphology score. As predicted, drinking behavior is a relatively strong predictor of child physical characteristics (β = 0.61, p < .001), even when all other maternal risk variables are included; higher levels of drinking predict child physical anomalies. Conclusions Overall, the SEM model explains 62% of the variance in child physical anomalies. As expected, drinking variables explain the most variance. But this highly controlled estimation of multiple effects also reveals a significant contribution played by maternal demographics and, to a lesser degree, maternal physical and childbearing variables.